missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Ibalizumab Humanized Recombinant Human Monoclonal Antibody
Human Recombinant Monoclonal Antibody
Marque: Invitrogen™ MA541841
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Ibalizumab (also known asibalizumab-uiykand formerly known as TNX-355) is a monoclonal antibody that binds to CD4 receptors on the surface of CD4-positive cells, preventing HIV particle entry into the lymphocytes. It is an advanced and current antibody in development for the treatment of HIV/AIDS. It has been developed by Taimed biologics and Theratechnologies 8, 5.
Spécification
| Ibalizumab Humanized | |
| Recombinant Monoclonal | |
| Unconjugated | |
| Hu5A8; TMB-355; TNX-355 | |
| Human CD4 D3 domain. | |
| 100 μg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid | |
| Chemical |
| ELISA, SDS-Page | |
| 1.91 mg/mL | |
| PBS with no preservative; pH 7.4 | |
| Human | |
| Protein A/G | |
| RUO | |
| Human | |
| Antibody | |
| IgG4 κ |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu